Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2004

Main Data: 31/12 Year 2004 
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 371.10
– gross margin 148.41
– total operating cost 111.06
– net operating profit 32.00
– financial expenses, net 4.18
– net income before taxes 13.30

 

Consolidated balance sheet Millions/Euro
– operating capital 75.12
– fixed assets, net 110.48
– reserves and MLT non financial payables – 17.51
– net financial position – 71.58
– stockholders’ equity 96.51

 

Other information Millions/Euro
– depreciation 15.86
– R & D expenses 17.35

 

  Euro
Dividend per share 0.40

 

  No.
Employees 2,480

 

  Euro
Share outstanding 18,772,000

 

Main Data: 30/06 Year 2004
Consolidated statement of income (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 150.48
– gross margin 61.63
– total operating cost 54.95
– net operating profit 4.13
– financial expenses, net 2.25
– net income before taxes 1.83

 

Consolidated balance sheet Millions/Euro
– operating capital 86.96
– fixed assets, net 100.81
– reserves and MLT non financial payables -14.32
– net financial position 87.53
– stockholders’ equity 85.92

 

Other information Millions/Euro
– depreciation 7.50
– R & D expenses 9.14

 

  No.
Employees 2,438

 

  Euro
Share outstanding 18,772,000

 

Net sales by sector: Year 2004
  Millions/Euro  
tea, herbs & coffee 65.69 17.70%
pharmaceuticals packaging 202.09 54.46%
pharmaceuticals processing 103.32 27.84%
Total 371.10 100.00%

 

Net sales by Country: Year 2004
  Millions/Euro  
E.U. (excluding Italy) 150.42 40.53%
Other European countries 26.06 7.02%
North America 75.13 20.25%
Asia & Middle East 54.42 14.66%
Other countries 34.36 9.26%
Total exports 340.39 91.72%
Italy 30.71 8.28%
Total 371.10 100.00%